Platelet activation in subjects with impaired glucose tolerance

Platelets

Volumn 18, Issue 8, 2007, Pages 591-594

  Coban, Erkan ^a   Kucuktag, S ^a   Basyigit, S ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Cardiovascular risk; Impaired glucose tolerance; Mean platelet volume; Platelet activation

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; THROMBOSIS;

ADULT; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELL SIZE; GLUCOSE INTOLERANCE; HUMANS; MIDDLE AGED; PLATELET ACTIVATION; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

MOROCCAN PEPPER VIRUS;

EID: 36549067765     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701609019     Document Type: Article

References (39)

1. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002;287:2570-2581.
2. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: The current status on definition and intervention. Diabet Med 2002;19:708-723.
3. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-240.
4. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
5. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000;23:S4-19.
6. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
7. Mukhopadhyay P, Chowdhury S. Drug therapy in prediabetes. J Indian Med Assoc 2005;103:603-608.
8. Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, Ballantyne CM. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: The atherosclerosis risk in communities study. Diabetes Care 2007;30:325-331.
9. Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Numao T, Fukuda T, Shimada K, Kazuomi, Kario K. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes. Hypertens Res 2007;30:23-30.
10. Gao W, Qiao Q, Tuomilehto J. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events. Clin Lab 2004;50:609-615.
11. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care 1999;22:920-924.
12. Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R, Tuomilehto J. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002;23:1267-1275.
13. Meigs JB, Nathan DM, D'Agostino Sr RB, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care 2002;25:1845-1850.
14. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405.
15. Calles-Escandon J, Garcia-Rubi E, Mirza S, Mortensen A. Type 2 diabetes: One disease, multiple cardiovascular risk factors. Coron Artery Dis 1999;10:23-30.
16. Bath PM, Carney C, Markandu ND, MacGregor GA. Platelet volume is not increased in essential hypertension. J Hum Hypertens 1994;8:457-459.
17. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002;13:301-306.
18. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117:399-404.
19. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338:1409-1411.
20. Tschoepe D, Esser J, Schwippert B, Rosen P, Kehrel B, Niewuenhuis HK, Gries FA. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 1991;17:433-439.
21. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004;35:1688-1691.
22. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-161.
23. Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005;59:981-982.
24. Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992;14:281-287.
25. Bath PM, Missouris CG, Buckenham T, MacGregor GA. Increased platelet volume and platelet mass in patients with atherosclerotic renal artery stenosis. Clin Sci (Lond) 1994;87:253-257.
26. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993;86:739-742.
27. Tschope D, Langer E, Schauseil S, Rosen P, Kaufmann L, Gries FA. Increased platelet volume-sign of impaired thrombopoiesis in diabetes mellitus. Klin Wochenschr 1989;67:253-259.
28. Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications 2004;18:173-176.
29. Papanas S, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004;15:475-478.
30. Friedewald WT, Levi RI, Fredricksen DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
31. Bath PM. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost 1993;70:687-690.
32. Erhart S, Beer JH, Reinhart WH. Influence of aspirin on platelet count and volume in humans. Acta Haematol 1999;101:140-144.
33. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006;17:67-69.
34. Dogru T, Tasci I, Sonmez A, Genc H, Gok M, Yilmaz MI, Ural AU, Olgun A, Kilic S, Bozoglu E, et al. The plasma levels of soluble P-selectin in subjects with prediabetes. Int J Clin Pract 2006;60:1048-1052.
35. Koltai K, Feher G, Kesmarky G, Keszthelyi Z, Czopf L, Toth K. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests. Clin Hemorheol Microcirc 2006;35:517-525.
36. Gokulakrishnan K, Deepa R, Mohan V, Gross MD. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome - the Chennai Urban Rural Epidemiology Study. Metabolism 2006;55:237-242.
37. Maiello M, Boeri D, Bonadonna R, Odetti P, Saccarello A, Adezati L. Platelet and clotting activities after cold stress in diabetic patients. Thromb Res 1988;50:885-894.
38. Schafer A, Widder J, Eigenthaler M, Bischoff H, Ertl G, Bauersachs J. Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose. Thromb Haemost 2004;92:97-103.
39. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose - a review of diagnosis, clinical implications and management. Diab Vasc Dis Res 2005;2:9-15.